Can GSTP1 variants reduce glutathione-conjugation capacity and affect thyroid hormone production and signaling?

The thyroid gland operates within a highly oxidative environment, relying on a delicate redox balance where glutathione-mediated detoxification plays a key protective role.

Impact of GSTP1 variants on conjugation

• The GSTP1 Ile105Val polymorphism (A313G in exon 5) alters the enzyme's hydrophobic substrate-binding H-site, modifying global detoxification performance.
• Individuals carrying the heterozygous Ile/Val (AG) or homozygous Val/Val (GG) genotypes exhibit a threefold lower conjugation capacity for standard model substrates like 1-chloro-2,4-dinitrobenzene (CDNB) compared to the wild-type.
• Despite this general reduction in conjugation capacity, the Val105 variant displays an approximate sevenfold higher catalytic efficiency specifically toward polycyclic aromatic hydrocarbon (PAH) diol epoxides.

Oxidative stress and thyroid disruption

• Depleted glutathione (GSH) reserves impair the enzymatic degradation of hydrogen peroxide ($H_2O_2$) by glutathione peroxidases (GPx), leaving thyrocytes highly vulnerable to oxidative stress.
• Elevated reactive oxygen species (ROS) directly downregulate the expression of essential thyroid hormone synthesis genes, including NIS, TPO, Tg, and TSHR, thereby reducing thyroxine ($T_4$) and triiodothyronine ($T_3$) output.
• Because glutathione acts as an essential cofactor for deiodinases, oxidative stress impairs the activating type 1 (D1) and type 2 (D2) deiodinases. Concurrently, it stimulates the inactivating type 3 deiodinase (D3), shifting the local tissue economy toward thyroid hormone inactivation.

Bottom line

• Inherited GSTP1 variants, such as the Val105 allele, compromise general glutathione-conjugation capacity and elevate cellular susceptibility to oxidative stress. This redox imbalance directly suppresses thyroid hormone synthesis gene expression and skews peripheral metabolism toward hormone inactivation by altering deiodinase pathway activity.